Australian court backs Myriad in human gene patent dispute


A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented.

Myriad, cancer, gene patents, Australia, Federal Court

More on this story

US Supreme Court strikes Myriad blow